Arbutus Biopharma Corp
$4.77
The Read: Arbutus Biopharma’s final procedural catalysts, including patent litigation verdicts and oral hearings, have historically triggered median absolute stock moves of about 5%.
ABUS
Hover to view data
No Data
By creating an account you agree to our Terms of Service and Privacy Policy.
$4.77
The Read: Arbutus Biopharma’s final procedural catalysts, including patent litigation verdicts and oral hearings, have historically triggered median absolute stock moves of about 5%.
No Data